Latest news from Argenta

30/11/2012

Hon Steven Joyce Visits Argenta

Hon Steven Joyce Visits Argenta

"Another gr8 kiwi co. Selling to the world - this time in animal health."

To view Doug & Steven on tour at Argenta click on the link https://twitter.com/stevenljoycepic.twitter.com/kYBXAiqm

26/11/2012

Media Release - Argenta Appoints new CEO

Media Release - Argenta Appoints new CEO

Auckland-based animal health contract research and manufacturing company Argenta today announced it has appointed Mr. David Biland, as its new CEO reporting to Founder and Managing Director, Dr. Doug Cleverly.

Dr. Cleverly has led the business through startup and rapid growth. The appointment of a new CEO is a major strategic decision for Argenta as the company moves into a phase of continuous growth, says Dr. Cleverly. “How to make this happen and find the best person for the business from a leadership, experience and values perspective, then to attract  them to New Zealand, could have been a massive challenge. Luckily I had someone in mind.”
Dr. Cleverly and Mr. Biland worked together in the late 1990’s, “He demonstrated a strong ability to think strategically and I developed a great deal of respect for him.”
Mr. Biland has held positions at Merial as head of Merial Australia and Ancare Australia based in Sydney, MD of New Zealand, MD UK, Scandinavia and Republic of Ireland and Regional Head of the Large Animals Business for Europe, Middle East, Indian sub-continent and Africa.  “He has a significant ability to manage large companies, the complexity and the challenges that come with that.” says Dr. Cleverly. “He’s a Kiwi coming home to take up this position, it’s always great see talent returning back to NZ and personally pleasing that the Argenta opportunity was an attractive one.” Mr. Biland said that he is very aware that there are not many opportunities like this in NZ and that there is no other company who does what Argenta does so this opportunity has really excited him.”
Argenta is a contract research and contract manufacturing organization (CRO/CMO) specializing in animal health pharmaceuticals that provides the full range of contract services from pre-clinical through to commercial product manufacture. With subsidiaries in New Jersey and Kansas, Argenta’s products and services are exported to more than 36 countries including United States, Europe, Canada and Japan. Argenta was formed in 2006 and since then has enjoyed stellar growth, a CAGR of 30% and staff numbers increasing from 70 at inception to over 220 today.

For further information contact:

Dr. Doug Cleverly, MD, Argenta
Tel: +64 9 250 3100
Email: doug.cleverly@argentaglobal.com